TIPS in Patients With Decompensated Liver Cirrhosis
Condition(s) studied
Investigational drug(s) / intervention(s)
TIPS insertion: Patients are included in the registry if they receive a transjugular intrahepatic portosystemic shunt at Hannover Medical School and provide written informed consent.
Study summary
This is a single center patient registry of patients receiving a transjugular intrahepatic portosystemic shunt (TIPS) at Hannover Medical School. By collecting and analyzing clinical data as well as blood samples, the overall aim is to optimize TIPS therapy (e.g. specify selection criteria).
Eligibility
Primary outcome measure(s)
- Mortality — 1 year
Patients who die within 1 year - Occurrence of (Minimal) Hepatic Encephalopathy — 1 year
Using the Portosystemic encephalopathy (PSE) syndrome test, critical flicker frequency (CFF) and animal naming test (S-ANT) - Change in Nutritional Status — 1 year
Nutritional Status will be measured by hand grip strength (dynamometer) in kg - Change in Quality of Life — 1 year
Using the questionnaire short-form 36 (SF36) (Score range 0-100, higher scores correspond to better quality of life)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hannover Medical School | Hanover | Lower Saxony | Recruiting |
More Hannover Medical School trials in Germany
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04801290 on ClinicalTrials.gov ↗ ← All trials in Germany